Imagion Biosystems Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

ASX:IBX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Dec 24	BuyAU$74,996	Brett Mitchell	Individual	3,750,000	AU$0.02
13 Dec 24	BuyAU$24,999	Robert Proulx	Individual	1,250,000	AU$0.02
27 Jun 24	BuyAU$1,744	Brett Mitchell	Individual	20,908	AU$0.083
19 Jun 24	BuyAU$40,251	Brett Mitchell	Individual	500,000	AU$0.09

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IBX?
Owner Type	Number of Shares	Ownership Percentage
Institutions	2,050,000	1.02%
Private Companies	21,103,336	10.5%
Individual Insiders	27,232,424	13.5%
General Public	150,955,655	75%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 516.7%.

Top Shareholders

Top 21 shareholders own 25.03% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.98%	Andrew Jones	6,000,000	AU$78.0k	0%	no data
2.12%	Brett Mitchell	4,270,908	AU$55.5k	0%	no data
2.04%	Blackburne Capital Pty Ltd	4,098,512	AU$53.3k	0%	no data
1.77%	Plutus Ventures Pty Ltd	3,556,936	AU$46.2k	0%	no data
1.67%	Mohammed Asem	3,357,132	AU$43.6k	0%	no data
1.64%	Nicholas Mcdonald	3,300,000	AU$42.9k	0%	no data
1.49%	Riqueza Ventures Pty Ltd	3,000,000	AU$39.0k	0%	no data
1.13%	Diane Mitchell	2,271,223	AU$29.5k	0%	no data
1.13%	William Mitchell	2,271,223	AU$29.5k	0%	no data
1.09%	Andrew Chapman	2,194,964	AU$28.5k	0%	no data
1.09%	Bythorne Contracting Pty Ltd	2,194,964	AU$28.5k	0%	no data
1.06%	Michelle Mitchell	2,135,454	AU$27.8k	0%	no data
1.06%	Nysha Investments Pty Ltd	2,134,174	AU$27.7k	0%	no data
1.05%	Danteen Pty Ltd	2,118,750	AU$27.5k	0%	no data
1.02%	Mercer Street Capital Partners, LLC	2,050,000	AU$26.7k	0%	2.07%
0.99%	Porjed Pty Ltd	2,000,000	AU$26.0k	0%	no data
0.99%	Long Tall Kathy Pty Ltd	2,000,000	AU$26.0k	0%	no data
0.7%	Robert Proulx	1,404,082	AU$18.3k	0%	no data
0.0068%	David Ludvigson	13,625	AU$177.2	0%	no data
0.0036%	Mark Van Asten	7,313	AU$95.0	0%	no data
0.0032%	Michael Harsh	6,500	AU$84.5	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/30 21:25
End of Day Share Price	2025/04/30 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Imagion Biosystems Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.